Allison David D. 4
4 · IMPEL NEUROPHARMA INC · Filed Jul 13, 2021
Insider Transaction Report
Form 4
Allison David D.
Director
Transactions
- Award
Stock Option (right to buy)
2021-07-11+11,500→ 11,500 totalExercise: $9.96Exp: 2031-07-10→ Common Stock (11,500 underlying)
Footnotes (1)
- [F1]The option is 100% vested on July 11, 2022.